ClinicalTrials.gg

Program

birch triterpenes

Also written as “Oleogel-S10”, “Oleogel-S10 ointment” and “Oleogel-S10 100 mg/g”.

Its studies are mostly in Epidermolysis Bullosa · Epidermolysis Bullosa Dystrophica · Burns · Keratosis, Actinic, led by Chiesi Farmaceutici.

Furthest: phase 3, since Jul 29, 20126 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Chiesi Farmaceutici61 open or runningphase 3since Jul 29, 2012Nov 5, 2008none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Nov 5, 2008First study: phase 2 study in Keratosis, ActinicFirst studyNCT00786994 · 165 enrolled · Germany, Greece
  2. Apr 14, 2010Phase 2 study in Accelerating the Epithelialization of Split Thickness Skin GraftNCT01294254 · 24 enrolled · Germany
  3. Oct 27, 2010Phase 2 study in Epidermolysis BullosaNCT01294241 · 10 enrolled · Germany
  4. Jul 29, 2012Phase 3 study in BurnsNCT01657292 · 61 enrolled · Germany, Sweden, Switzerland and more
  5. Feb 27, 2017Phase 3 study in Epidermolysis BullosaNCT03068780 · 223 enrolled · United States, Argentina, Australia and more
  6. Mar 17, 2025Phase 3 study in Epidermolysis BullosaNCT06917690 · 6 planned · Japan

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 6 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT06917690Epidermolysis Bullosa · Japan3RecruitingMar 20266
NCT03068780Epidermolysis Bullosa · United States, Argentina, Australia and more3CompletedJun 11, 2020223
NCT01657292Burns · Germany, Sweden, Switzerland and more3CompletedJul 201361
NCT01294241Epidermolysis Bullosa · Germany2CompletedJun 201110
NCT01294254Accelerating the Epithelialization of Split Thickness Skin Graft · Germany2CompletedNov 201024
NCT00786994Keratosis, Actinic · Germany, Greece2CompletedNov 2010165

How it is read

Names in the registry

  • “Oleogel-S10”, 4 entries
  • “Oleogel-S10 ointment”, 1 entry
  • “Oleogel-S10 100 mg/g”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.